Company / Current Liabilities per Share
Astria Therapeutics, Inc. Current Liabilities per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.34
FY2024
5-year range
$0.34 / $2.09
FY2020-FY2024
Trend
-11.2%
vs FY2023
Sector context
#169 of 210
Health Care
What the data says
Astria Therapeutics, Inc.'s current liabilities per share of $0.34 is lower than 80% of companies in the Health Care sector (FY2024). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $0.34 in FY2024 to $2.77 in FY2017.
Based on SEC 10-K filings.
0.34 in FY2024 with a 5-year CAGR of -8.1%.
Improved from $0.62 to $0.34 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -16.4%
- 5-Year CAGR
- -8.1%
- 10-Year CAGR
- -
Sector benchmark
-98.6% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share decreased 11.2% year-over-year.
- Ranks #169 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.34 | -11.2% |
| FY2023 | $0.38 | -38.1% |
| FY2022 | $0.62 | +6.3% |
| FY2021 | $0.58 | -72.1% |
| FY2020 | $2.09 | +302.2% |
| FY2019 | $0.52 | -37.0% |
| FY2018 | $0.83 | -70.3% |
| FY2017 | $2.77 | +441.0% |
| FY2016 | $0.51 | -47.0% |
| FY2015 | $0.97 | -90.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026